{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:29:42Z","timestamp":1761154182689,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1006\/clin.1997.4348","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Strong Augment Effect of IL-12 Expression Plasmid on the Induction of HIV-Specific Cytotoxic T Lymphocyte Activity by a Peptide Vaccine Candidate"],"prefix":"10.1006","volume":"83","author":[{"given":"Kenji","family":"Hamajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Bukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamiko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuusuke","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Qin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4348_II974348C1","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1073\/pnas.85.12.4478","article-title":"Human immuunodeficiency virus type 1 neutralization epitope with conserved architecture elicite early type-specific antibodies in experimentary infected chimpanzees","volume":"85","author":"Goudsmit","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4348_II974348C2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1126\/science.2830667","article-title":"Second conserved domain of gp 120 is important for HIV infectivity and antibody neutralization","volume":"239","author":"Ho","year":"1988","journal-title":"Science"},{"key":"10.1006\/clin.1997.4348_II974348C3","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.87.18.7045","article-title":"HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals","volume":"87","author":"Achour","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4348_II974348C4","first-page":"462","article-title":"Mucosal immunity to HIV. Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4\/V3 peptide T1SP10 MN(A)","volume":"156","author":"Staats","year":"1966","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm0795-681","article-title":"Neutralization of HIV-1 secretory Ig A induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate","volume":"1","author":"Bukawa","year":"1996","journal-title":"Nature Med."},{"key":"10.1006\/clin.1997.4348_II974348C6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0264-410X(93)90046-Z","article-title":"Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in attenuatedaroASalmonella typhimuriumEscherichia coli","volume":"11","author":"Charbit","year":"1993","journal-title":"Vaccine"},{"key":"10.1006\/clin.1997.4348_II974348C7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/aid.1993.9.395","article-title":"Immunogenicity of recombinant human adenovirus\u2013human immunodeficiency virus vaccines in chimpanzees","volume":"9","author":"Natuk","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clin.1997.4348_II974348C8","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/jvi.68.5.3145-3153.1994","article-title":"Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine","volume":"68","author":"Johnson","year":"1994","journal-title":"J. Virol."},{"key":"10.1006\/clin.1997.4348_II974348C9","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1089\/aid.1994.10.1433","article-title":"A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine","volume":"11","author":"Fuller","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clin.1997.4348_II974348C10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/aid.1995.11.933","article-title":"Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the type 1envrev","volume":"11","author":"Okuda","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clin.1997.4348_II974348C11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.170.3.827","article-title":"Identification and purification of natural killer cell stimulatory factor (NKSF), a factor with multiple biologic effects on human lymphocytes","volume":"170","author":"Kobayashi","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4348_II974348C12","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1073\/pnas.87.17.6808","article-title":"Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells","volume":"87","author":"Stern","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4348_II974348C13","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.146.9.3074","article-title":"Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effect on T and natural killer cells","volume":"146","author":"Wolf","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C14","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1073\/pnas.88.10.4143","article-title":"Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor","volume":"88","author":"Gubler","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4348_II974348C15","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.148.11.3433","article-title":"Cloning and expression of murine IL-12","volume":"148","author":"Schoenhaut","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of Interferon-\u03b3 production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4348_II974348C17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.177.6.1797","article-title":"Resolution of cutaneous Leishmaniases: Interleukin 12 initiates a protective T helper type 1 immune response","volume":"177","author":"Sypek","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4348_II974348C18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.177.5.1505","article-title":"Recombinant interleukin 12 cures mice infected with Leishmania major","volume":"177","author":"Heinzel","year":"1993","journal-title":". J. Exp. Med."},{"key":"10.1006\/clin.1997.4348_II974348C19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Antitumor and antimetastatic activity of interleukin-12 against murine tomors","volume":"178","author":"Brunda","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4348_II974348C20","first-page":"97","article-title":"Strong synergistic effect of multicomponent vaccine for human immunodeficiency virus infection","volume":"40","author":"Okuda","year":"1993","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1348-0421.1995.tb02249.x","article-title":"Antibody responses rainsed against a conformational V3 loop peptide of HIV-1","volume":"39","author":"Bukawa","year":"1995","journal-title":"Microbiol. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/clin.1995.1165","article-title":"A macromolecular multicomponent peptide vaccine prepared using the glutaraldehyde conjugation with strong immunogenicity for HIV-1","volume":"77","author":"Hamajima","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1997.4348_II974348C23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00002030-199109000-00015","article-title":"Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1 infected individuals","volume":"5","author":"Inami","year":"1991","journal-title":"AIDS"},{"key":"10.1006\/clin.1997.4348_II974348C24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/169.1.227","article-title":"A serologic analysis and amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok","volume":"169","author":"Okuda","year":"1994","journal-title":"J. Inf. Dis."},{"key":"10.1006\/clin.1997.4348_II974348C25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(94)91825-2","article-title":"Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand","volume":"344","author":"Ubolyam","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/clin.1997.4348_II974348C26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/0042-6822(92)90249-O","article-title":"Synergistic interaction between ligands to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120","volume":"191","author":"Mckeating","year":"1992","journal-title":"Virology"},{"key":"10.1006\/clin.1997.4348_II974348C27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0169-328X(95)00005-D","article-title":"Expression and characterization of the \u03b61 subunit of the N-methyl-d-asparate (NMDA) receptor channel in a baculovirus system","volume":"30","author":"Kawamoto","year":"1955","journal-title":"Mol. Brain. Res."},{"key":"10.1006\/clin.1997.4348_II974348C28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0008-8749(95)80031-D","article-title":"Studies onin vivo","volume":"160","author":"Nehete","year":"1995","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1997.4348_II974348C29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukariotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1006\/clin.1997.4348_II974348C30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/dna.1994.13.429","article-title":"Semiquantitative, nonradioactive RT\u2013PCR detection of immunoglobulin mRNA in human B cells","volume":"13","author":"Davis","year":"1994","journal-title":"DNA Cell Biol."},{"key":"10.1006\/clin.1997.4348_II974348C31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2431484","article-title":"CD8+","volume":"234","author":"Walker","year":"1986","journal-title":"Science"},{"key":"10.1006\/clin.1997.4348_II974348C32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.271.5247.324","article-title":"Toward an understanding of the correlates of protective immunity to HIV infection","volume":"271","author":"Haynes","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1997.4348_II974348C33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.272.5261.505","article-title":"AIDS pathogenesis: A finite immune response to blame?","volume":"272","author":"Miedema","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1997.4348_II974348C34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/344873a0","article-title":"Induction of CD8+","volume":"44","author":"Takahashi","year":"1990","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4348_II974348C35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1126\/science.1598588","article-title":"Galactose oxidation in the design of immunogenic vaccines","volume":"256","author":"Zheng","year":"1992","journal-title":"Science"},{"key":"10.1006\/clin.1997.4348_II974348C36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/aid.1994.10.853","article-title":"Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251gagenv","volume":"10","author":"Newman","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clin.1997.4348_II974348C37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvant\u2014A balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1006\/clin.1997.4348_II974348C38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0192-0561(94)90090-6","article-title":"T-cell adjuvants","volume":"16","author":"Haddden","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1006\/clin.1997.4348_II974348C39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1749-6632.1995.tb44445.x","article-title":"Vaccine strategies: Targeting helper T cell responses","volume":"754","author":"Golding","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/clin.1997.4348_II974348C40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014Current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1006\/clin.1997.4348_II974348C41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0192-0561(94)00095-6","article-title":"The role of adjuvants in retroviral vaccines","volume":"17","author":"Vogel","year":"1995","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1006\/clin.1997.4348_II974348C42","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1084\/jem.178.4.1309","article-title":"Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvants selectively induces Th2 cells in mucosa associated tissues","volume":"178","author":"Xu-Amano","year":"1993","journal-title":"J. Exp. Med."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997943488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997943488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:11:56Z","timestamp":1758762716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997943488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["S0090122997943488"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4348","relation":{},"ISSN":["0090-1229"],"issn-type":[{"type":"print","value":"0090-1229"}],"subject":[],"published":{"date-parts":[[1997,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strong Augment Effect of IL-12 Expression Plasmid on the Induction of HIV-Specific Cytotoxic T Lymphocyte Activity by a Peptide Vaccine Candidate","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}